Corporate News
2024
Director/PDMR Shareholding
04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Adam Reynolds | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Chairman | |||
b) | Initial notification /Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | MYHEALTHCHECKED plc | |||
b) | LEI | 213800RBHY6LZDG13168 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares | |||
Identification code | ISIN: GB00BYZ2R301 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.7 pence | 1,000,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single Transaction | ||||
- Price | |||||
e) | Date of the transaction | 3 August 2022 | |||
f) | Place of the transaction | London Stock Exchange - AIMX | |||
2023
Director/PDMR Shareholding
04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Adam Reynolds | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Chairman | |||
b) | Initial notification /Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | MYHEALTHCHECKED plc | |||
b) | LEI | 213800RBHY6LZDG13168 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares | |||
Identification code | ISIN: GB00BYZ2R301 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.7 pence | 1,000,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single Transaction | ||||
- Price | |||||
e) | Date of the transaction | 3 August 2022 | |||
f) | Place of the transaction | London Stock Exchange - AIMX | |||
2022
Director/PDMR Shareholding
04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Adam Reynolds | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Chairman | |||
b) | Initial notification /Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | MYHEALTHCHECKED plc | |||
b) | LEI | 213800RBHY6LZDG13168 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares | |||
Identification code | ISIN: GB00BYZ2R301 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.7 pence | 1,000,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single Transaction | ||||
- Price | |||||
e) | Date of the transaction | 3 August 2022 | |||
f) | Place of the transaction | London Stock Exchange - AIMX | |||
2021
Director/PDMR Shareholding
04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Adam Reynolds | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Chairman | |||
b) | Initial notification /Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | MYHEALTHCHECKED plc | |||
b) | LEI | 213800RBHY6LZDG13168 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares | |||
Identification code | ISIN: GB00BYZ2R301 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.7 pence | 1,000,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single Transaction | ||||
- Price | |||||
e) | Date of the transaction | 3 August 2022 | |||
f) | Place of the transaction | London Stock Exchange - AIMX | |||
2020
Director/PDMR Shareholding
04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Adam Reynolds | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Chairman | |||
b) | Initial notification /Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | MYHEALTHCHECKED plc | |||
b) | LEI | 213800RBHY6LZDG13168 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares | |||
Identification code | ISIN: GB00BYZ2R301 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.7 pence | 1,000,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single Transaction | ||||
- Price | |||||
e) | Date of the transaction | 3 August 2022 | |||
f) | Place of the transaction | London Stock Exchange - AIMX | |||
2019
Director/PDMR Shareholding
04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Adam Reynolds | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Chairman | |||
b) | Initial notification /Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | MYHEALTHCHECKED plc | |||
b) | LEI | 213800RBHY6LZDG13168 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares | |||
Identification code | ISIN: GB00BYZ2R301 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.7 pence | 1,000,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single Transaction | ||||
- Price | |||||
e) | Date of the transaction | 3 August 2022 | |||
f) | Place of the transaction | London Stock Exchange - AIMX | |||
2018
Director/PDMR Shareholding
04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Adam Reynolds | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Chairman | |||
b) | Initial notification /Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | MYHEALTHCHECKED plc | |||
b) | LEI | 213800RBHY6LZDG13168 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares | |||
Identification code | ISIN: GB00BYZ2R301 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.7 pence | 1,000,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single Transaction | ||||
- Price | |||||
e) | Date of the transaction | 3 August 2022 | |||
f) | Place of the transaction | London Stock Exchange - AIMX | |||
2017
Director/PDMR Shareholding
04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Adam Reynolds | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Chairman | |||
b) | Initial notification /Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | MYHEALTHCHECKED plc | |||
b) | LEI | 213800RBHY6LZDG13168 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares | |||
Identification code | ISIN: GB00BYZ2R301 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.7 pence | 1,000,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single Transaction | ||||
- Price | |||||
e) | Date of the transaction | 3 August 2022 | |||
f) | Place of the transaction | London Stock Exchange - AIMX | |||
2016
Director/PDMR Shareholding
04 August 2022
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
MyHealthChecked plc | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Adam Reynolds | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Chairman | |||
b) | Initial notification /Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | MYHEALTHCHECKED plc | |||
b) | LEI | 213800RBHY6LZDG13168 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares | |||
Identification code | ISIN: GB00BYZ2R301 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.7 pence | 1,000,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single Transaction | ||||
- Price | |||||
e) | Date of the transaction | 3 August 2022 | |||
f) | Place of the transaction | London Stock Exchange - AIMX | |||